JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Tax-Exempt Bond Index Fund
VTEB
|
+$2.54B |
| 2 |
Amazon
AMZN
|
+$1.38B |
| 3 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$827M |
| 4 |
Public Service Enterprise Group
PEG
|
+$725M |
| 5 |
Union Pacific
UNP
|
+$721M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.49B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.03B |
| 3 |
McDonald's
MCD
|
+$1.01B |
| 4 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$871M |
| 5 |
Exelon
EXC
|
+$709M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.28% |
| 2 | Healthcare | 12.84% |
| 3 | Financials | 10.61% |
| 4 | Consumer Discretionary | 7.72% |
| 5 | Industrials | 7.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2251
RH
RH
$3.44B
| $9.09M | ﹤0.01% |
34,033
-1,190
| -3% | -$310K |
|
|
ALE
2252
DELISTED
Allete
ALE
| $9.08M | ﹤0.01% |
140,748
-6,913
| -5% | -$410K |
|
2253
Liberty Energy
LBRT
$3.59B
| $9.07M | ﹤0.01% |
566,490
+426,765
| +305% | +$6.79M |
|
2254
United Natural Foods
UNFI
$2.93B
| $9.07M | ﹤0.01% |
234,325
+4,220
| +2% | +$175K |
|
2255
Tandem Diabetes Care
TNDM
$1.58B
| $9.07M | ﹤0.01% |
201,698
+40,695
| +25% | +$1.84M |
|
2256
Avis
CAR
$4.87B
| $9.06M | ﹤0.01% |
55,257
-112,799
| -67% | -$22.6M |
|
|
ROIC
2257
DELISTED
Retail Opportunity Investments Corp.
ROIC
| $9.05M | ﹤0.01% |
602,430
-943,816
| -61% | -$13.8M |
|
2258
O-I Glass
OI
$1.04B
| $9.05M | ﹤0.01% |
546,273
+137,501
| +34% | +$2.21M |
|
2259
PUT
Philip Morris
PM
$297B
| $9M | ﹤0.01% |
88,900
+15,900
| +22% | +$1.5M |
|
2260
DXC Technology
DXC
$1.72B
| $8.97M | ﹤0.01% |
338,477
-416,964
| -55% | -$11.6M |
|
2261
Dolby
DLB
$5.84B
| $8.97M | ﹤0.01% |
127,134
-37,396
| -23% | -$2.58M |
|
2262
CALL
UnitedHealth
UNH
$361B
| $8.96M | ﹤0.01% |
16,900
+12,200
| +260% | +$6.46M |
|
|
AZPN
2263
DELISTED
Aspen Technology Inc
AZPN
| $8.95M | ﹤0.01% |
43,590
-10,988
| -20% | -$2.55M |
|
2264
Twilio
TWLO
$36.6B
| $8.95M | ﹤0.01% |
182,804
-519,889
| -74% | -$29.6M |
|
|
BLUE
2265
DELISTED
bluebird bio
BLUE
| $8.95M | ﹤0.01% |
64,652
+3,308
| +5% | +$466K |
|
2266
iShares ESG Advanced MSCI EAFE ETF
DMXF
$972M
| $8.95M | ﹤0.01% |
164,840
+164,825
| +1,098,833% | +$8.53M |
|
2267
Vanguard Materials ETF
VAW
$3.07B
| $8.94M | ﹤0.01% |
52,521
+10,174
| +24% | +$1.71M |
|
2268
InMode
INMD
$872M
| $8.92M | ﹤0.01% |
249,843
+176,190
| +239% | +$6.13M |
|
2269
ATI
ATI
$31.1B
| $8.86M | ﹤0.01% |
296,615
-65,822
| -18% | -$1.93M |
|
|
MZTI
2270
The Marzetti Company
MZTI
$3.18B
| $8.85M | ﹤0.01% |
44,851
+831
| +2% | +$158K |
|
2271
iShares Intermediate Government/Credit Bond ETF
GVI
$3.8B
| $8.84M | ﹤0.01% |
86,309
+3,003
| +4% | +$307K |
|
2272
CVR Energy
CVI
$3.54B
| $8.84M | ﹤0.01% |
282,118
+46,088
| +20% | +$1.64M |
|
|
RADI
2273
DELISTED
Radius Global Infrastructure, Inc. Class A Common Stock
RADI
| $8.82M | ﹤0.01% |
746,035
+63,207
| +9% | +$655K |
|
|
RDUS
2274
DELISTED
Radius Recycling
RDUS
| $8.81M | ﹤0.01% |
287,361
-12,819
| -4% | -$396K |
|
2275
CALL
BioMarin Pharmaceuticals
BMRN
$13B
| $8.8M | ﹤0.01% |
+85,000
| New | +$7.98M |
|
Similar funds
JP Morgan Chase's Q4 2022 Portfolio in Review
As of Q4 2022, JP Morgan Chase held 7,423 positions worth $759B, up 8.9% from $696B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q4 2022 filing shows 753 new, 2,941 increased, 2,285 reduced and 594 closed positions. Its largest new stake was Invesco S&P Emerging Markets Low Volatility ETF: 2,344,997 shares worth $54M. The largest sale was Invesco QQQ Trust, an estimated $1.49B.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 15% a quarter earlier, followed by Healthcare and Financials.
- JP Morgan Chase's largest Q4 2022 buy was Invesco S&P Emerging Markets Low Volatility ETF: 2,344,997 shares worth $54M.
- JP Morgan Chase added most to Vanguard Tax-Exempt Bond Index Fund in Q4 2022, an estimated $2.54B increase.
- JP Morgan Chase's biggest Q4 2022 reduction was Invesco QQQ Trust, cutting an estimated $1.49B.
- JP Morgan Chase fully exited Duke Realty Corp. in Q4 2022, selling an estimated $424M.
- JP Morgan Chase's ten largest holdings make up 16% of its $759B portfolio in Q4 2022.
- JP Morgan Chase opened 753 new positions and closed 594 in Q4 2022.
- JP Morgan Chase's portfolio value rose 8.9% quarter-over-quarter to $759B.
Based on JP Morgan Chase's 13F filing for Q4 2022, filed 13 Feb 2023.